CLINICAL_TRIALS
trial_result
· 2021-03-19
Clinical Trial Update: Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients [Phase 4]
Summary
Phase 4 trial assessing pharmacokinetics of dalbavancin in intravenous and intraperitoneal administration for infectious peritonitis; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Infectious Peritonitis | Phase 4 | Status: COMPLETED | Results posted: 2021-03-19